Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 357-359

  Dias, R P ^a   Chan, L F ^a   Metherell, L A ^a   Pearce, S H S ^b   Clark, A J L ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RECEPTOR; MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; REGULATOR PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADOLESCENT; ADRENAL CORTEX INSUFFICIENCY; ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GENE; GENOTYPE; GLUCOCORTICOSTEROID DEFICIENCY; HUMAN; MALE; MC2R GENE; MRAP GENE; PRIORITY JOURNAL; PROMOTER REGION; STAR GENE;

ADDISON DISEASE; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 2; YOUNG ADULT;

EID: 75149193554     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0720     Document Type: Article

References (18)

1. Kong MF & Jeffcoate W. Eighty-six cases of Addison's disease. Clinical Endocrinology 1994 41 757-761.
2. Nerup J. Addison's disease - clinical studies. A report of 108 cases. Acta Endocrinologica 1974 76 127-141.
3. Addison T, Ed. On the Constitutional and Local Effects of Disease of the Suprarenal Capsules. In: A Collection of the Published Writings of the late Thomas Addison MD. London: New Syndenham Society, 1855.
4. Betterle C, Dal Pra C, Mantero F & Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 327-364.
5. Shepard TH, Landing BH & Mason DG. Familial Addison's disease; case reports of two sisters with corticoid deficiency unassociated with hypoaldosteronism. A.M.A. Journal of Diseases of Children 1959 97 154-162.
6. Chan LF, Metherell LA, Krude H, Ball C, O'Riordan SM, Costigan C, Lynch SA, Savage MO, Cavarzere P & Clark AJ. Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency are not associated with long-term mineralocorticoid deficiency. Clinical Endocrinology 2009 71 171-175.
7. Lin L, Hindmarsh PC, Metherell LA, Alzyoud M, Al-Ali M, Brain CE, Clark AJ, Dattani MT & Achermann JC. Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clinical Endocrinology 2007 66 205-210.
8. Chida D, Nakagawa S, Nagai S, Sagara H, Katsumata H, Imaki T, Suzuki H, Mitani F, Ogishima T, Shimizu C, Kotaki H, Kakuta S, Sudo K, Koike T, Kubo M & Iwakura Y. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. PNAS 2007 104 18205-18210.
9. Clark AJ, McLoughlin L & Grossman A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993 341 461-462.
10. Clark AJ, Metherell LA, Cheetham ME & Huebner A. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends in Endocrinology and Metabolism 2005 16 451-457.
11. Slawik M, Reisch N, Zwermann O, Maser-Gluth C, Stahl M, Klink A, Reincke M & Beuschlein F. Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH. Journal of Clinical Endocrinology and Metabolism 2004 89 3131-3137.
12. Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME & Clark AJ.Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nature Genetics 2005 37 166-170.
13. Metherell LA, Naville D, Halaby G, Begeot M, Huebner A, Nü rnberg G, Nü rnberg P, Green J, Tomlinson JW, Krone NP, Lin L, Racine M, Berney DM, Achermann JC, Arlt W & Clark AJL. Non-classic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 3865-3871.
14. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P & Pearce SH. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. Journal of Clinical Endocrinology and Metabolism 2000 85 688-691.
15. Baker BY, Lin L, Kim CJ, Raza J, Smith CP, Miller WL & Achermann JC. Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. Journal of Clinical Endocrinology and Metabolism 2006 91 4781-4785.
16. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R & Jaaskelainen J. ACTH receptor promoter polymorphism associates with severity of premature adrenarche and modulates hypothalamo-pituitary-adrenal axis in children. Pediatric Research 2008 63 410-414.
17. Proudnikov D, Hamon S, Ott J & Kreek MJ. Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction. Neuroscience Letters 2008 435 234-239.
18. O'Riordan SM, Lynch SA, Hindmarsh PC, Chan LF, Clark AJ & Costigan C. A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. Journal of Clinical Endocrinology and Metabolism 2008 93 2896-2899.